Amplimune™ Now Available in Canada
NovaVive is a private Canadian immunobiology company founded in July, 2014. The Company acquired an advanced veterinary immunotherapeutic platform based on mycobacterium cell wall fraction (MCWF) technology with regulator-approved products for cattle, horses and dogs. These products are currently sold to veterinarians in the U.S.A., Canada, Australia and New Zealand. The Company's head office is located in Belleville, Ontario, Canada.
Amplimune™ has received approval for sale in Canada by the Canadian Food Inspection Agency. The Company believes this is the first antibiotic alternative therapy for livestock to receive Canadian regulatory approval.
learn more
The results of clinical studies using MCW formulations in ameliorating neutropenia and inducing serum cytokine synthesis were presented at the 3rd World Veterinary Cancer Congress (WVCC) in May, 2016 in Brazil.
learn more
NovaVive Inc.'s cattle immunotherapy – Amplimune™ - has received certification by Northeast Organic Farming Association New York (NOFA-NY) and Quality Certification Services (QCS) for use in organic cattle production.
learn more
